“…In cross-sectional ANOVA with the EF, SF, and BFR groups, there was no difference among the three groups at baseline (P = 0.69), 4 mo (P = 0.63), 6 mo (P = 0.052), or 12 mo (P = 0.20) of age. There were no significant differences in proportion (n (%)) of infants excluded from the hsCRP analysis due to levels of ≥5 mg/l among the EF, SF, and BFR groups at baseline (0 (0), 1 (1), and 0 (0); P = 0.35), at 4 mo (5 (8), 3 (4), and 3 (5); P = 0.72), or 6 mo (7 (11), 4 (6), and 11 (19); P = 0.15). At 12 mo of age, the proportion (n (%)) of infants with hsCRP ≥ 5 was higher in the EF group (7 (12%)) compared with the SF group (0 (0%); P = 0.013) but not compared with the BFR group (1 (2%); P = 0.062).…”